Q3 Interim Management Statement
Synergy (SYR.L), a leading provider of specialist outsourced support services to health-related markets, is pleased to provide an update on trading performance since 30 September 2012.
Trading Update
Reported revenue for the nine months to 30 December 2012 increased by 13.9% to £264.7 million (Q3 2011/12: £232.5 million). Underlying revenue, excluding currency effects, was £273.0 million, 17.4% above last year.
Underlying revenue in the operating regions was as follows:
|
Underlying revenue* |
Q3 YTD 2012/13 |
Q3 YTD 2011/12 |
Growth |
|
UK & Ireland |
£119.6 million |
£117.8 million |
+ 1.5% |
|
Europe & Middle East |
£97.1 million |
£92.7 million |
+ 4.8% |
|
Asia & Africa |
£14.5 million |
£12.7 million |
+14.3% |
|
Americas AST |
£10.4 million |
£8.8 million |
+19.1% |
|
Americas Total** |
£41.8 million |
£9.3 million |
n/a |
|
Total |
£273.0 million |
£232.5 million |
+17.4% |
